Not available outside of the UK & Ireland.
Biochem/physiol Actions
Mosapride is found effective against chronic gastritis, functional dyspepsia and gastro-oesophageal reflux disease. It is useful in treating many other symptoms associated with gastrointestinal disorders. Mosapride is known to improve digestive motility.
5-HT4 receptor agonist and 5-HT3 receptor antagonist
Features and Benefits
This compound was developed by Takeda. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
Packaging
10, 50 mg in glass bottle
This product has met the following criteria to qualify for the following awards: